Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.49 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.49 |
| ▸ | CDK2 | P24941 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | SDHB | P21912 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenolsulphonic Acid SCHEMBL27515620 | 0.82 | SMN1; SMN2 (0.67) | SMN1; SMN2MAPK1TP53HSD17B10ALOX15 | |
| SCHEMBL6420160 | 0.76 | SMN1; SMN2 (0.61) | SMN1; SMN2MAPK1TP53HSD17B10CCNE2 | |
| SCHEMBL6414035 | 0.74 | SMN1; SMN2 (0.58) | SMN1; SMN2HSD17B10KDM4EL3MBTL1HPGD | |
| SCHEMBL1143192 | 0.74 | SMN1; SMN2 (0.58) | SMN1; SMN2HSD17B10CCNE2CCNE1CDK2 | |
| SCHEMBL6412005 | 0.74 | SMN1; SMN2 (0.58) | SMN1; SMN2HSD17B10ALOX15CCNE2CCNE1 | |
| SCHEMBL239535 | 0.72 | MAPK1 (0.62) | SMN1; SMN2MAPK1TP53HSD17B10ALOX15 | |
| SCHEMBL18279960 | 0.72 | ALOX15 (0.56) | SMN1; SMN2MAPK1TP53HSD17B10ALOX15 | |
| SCHEMBL4923288 | 0.71 | SMN1; SMN2 (0.55) | SMN1; SMN2HSD17B10KDM4EL3MBTL1RXFP1 | |
| SCHEMBL5904042 | 0.71 | SMN1; SMN2 (0.55) | SMN1; SMN2MAPK1TP53HSD17B10ALOX15 | |
| SCHEMBL12980199 | 0.70 | SMN1; SMN2 (0.54) | SMN1; SMN2MAPK1TP53HSD17B10ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7285554-B2 | Pyrazolyl-substituted benzene or thiophene coupled to an aryl, cycloalkyl or heteroaryl ring by an amide, e.g., 4'-chloro-5-(1,4-dimethyl-5-trifluoromethyl-1H-pyrazol-3-yl)thiophene-2-carboxyanilide; calcium release-activated calcium channel inhibitors; treating bronchial asthma and rheumatoid arthritis | ASTELLAS PHARMA INC. (JP) | 2007-10-23 | — | — | US | disclosed |
| US-7247635-B2 | Pyrazole derivative | ASTELLAS PHARMA INC. (JP) | 2007-07-24 | — | — | US | disclosed |
| EP-1024138-B1 | PYRAZOLE DERIVATIVES | ASTELLAS PHARMA INC (JP) | 2007-04-25 | — | — | EP | disclosed |
| US-20060264430-A1 | Pyrazolyl-substituted benzene or thiophene coupled to an aryl, cycloalkyl or heteroaryl ring by an amide, e.g., 4'-chloro-5-(1,4-dimethyl-5-trifluoromethyl-1H-pyrazol-3-yl)thiophene-2-carboxyanilide; calcium release-activated calcium channel inhibitors; treating bronchial asthma and rheumatoid arthritis | ASTELLAS PHARMA INC. | 2006-11-23 | — | — | US | disclosed |
| US-6958339-B2 | Pyrazole derivative | ASTELLAS PHARMA INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20050234055-A1 | Pyrazole derivative | ASTELLAS PHARMA INC. | 2005-10-20 | — | — | US | disclosed |
| US-20050048092-A1 | Thienyl-pyrazoles and their use for controlling pests | WADA KATSUAKI (JP) | 2005-03-03 | — | — | US | disclosed |
| US-6593358-B1 | Method for controlling pests, comprising the step of allowing a pesticidally effective amount of one or more compounds selected from the group consisting of one or more compounds of the formula (Ia) according to claim 2 and one or compounds | NIHON BAYER AGROCHEM K.K. (JP) | 2003-07-15 | — | — | US | disclosed |
| EP-1200425-A1 | THIENYL-PYRAZOLES AND THEIR USE FOR CONTROLLING PESTS | NIHON BAYER AGROCHEM K.K. (JP) | 2002-05-02 | — | — | EP | disclosed |
| US-6348480-B1 | CALCIUM CHANNEL BLOCKERS AND ANTIINFLAMMATORY AGENTS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 2002-02-19 | — | — | US | disclosed |
| US-20010011090-A1 | Pyrazole derivative | ASTELLAS PHARMA INC. (JP) | 2001-08-02 | — | — | US | disclosed |
| WO-2001005787-A1 | THIENYL-PYRAZOLES AND THEIR USE FOR CONTROLLING PESTS | NIHON BAYER AGROCHEM K.K. (DE) | 2001-01-25 | — | — | WO | disclosed |
| EP-1024138-A1 | PYRAZOLE DERIVATIVES | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 2000-08-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050234055-A1 | Pyrazole derivative | RYR2, RYR1, NR1I3 | SMN1; SMN2 4190/4885MAPK1 1390/4885TP53 3863/4885 |
| US-20060264430-A1 | Pyrazolyl-substituted benzene or thiophene coupled to an aryl, cycloalkyl or heteroaryl ring by an amide, e.g., 4'-chloro-5-(1,4-dimethyl-5-trifluoromethyl-1H-pyrazol-3-yl)thiophene-2-carboxyanilide; calcium release-activated calcium channel inhibitors; treating bronchial asthma and rheumatoid arthritis | RYR2, HRH4, RYR1 | SMN1; SMN2 4791/4885MAPK1 1747/4885TP53 3815/4885 |
| US-20010011090-A1 | Pyrazole derivative | RYR1, CACNA1E, RYR2 | SMN1; SMN2 3702/4885MAPK1 688/4885TP53 4226/4885 |
| US-20050048092-A1 | Thienyl-pyrazoles and their use for controlling pests | CBR3, C1S, CYP4B1 | SMN1; SMN2 4328/4885MAPK1 2860/4885TP53 4132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.